Important informations

Our researchers

Aucun résultat

Dr. Shireen Sirhan

Shireen Sirhan, MDCM, MSc, FRCPC


Essential thrombocytosis, MPN, Myelofibrosis, Myeloproliferative, Polycythemia Vera
  • Associate Researcher, Lady Davis Institute for Medical Research
  • Hematologist, Myeloproliferative Disorders Clinic, Segal Cancer Centre, Jewish General Hospital
  • Assistant Professor, Gerald Bronfman Department of Oncology, McGill University

Contact details

(514) 340-8222 ext. 28434

Research Interests

Dr. Shireen Sirhan co-established the first Myeloproliferative Neoplasms (MPN) clinic in Canada at the Jewish General Hospital, where specialized multidisciplinary care and access to specialised testing and clinical trials is offered. She is the principal investigator on several clinical trials that have helped providing access to novel agents in the field of MPNs.

She is a founding member and the current President of the Canadian MPN group, and Vice-President for research in MPNs of the Groupe Québécois de recherche en LMC-NMP. She also serves as member of advisory board for Canadian MPN Research Foundation.

Research interests include:

  • Novel treatments of Myeloproliferative Neoplasms (MPNs)
  • AI/Machine Learning applications for MPN diagnosis and treatment
  • Molecular Correlates of Prognosis and treatment response in MPNs